Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer-Reference-Cited by-同舟云学术

Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer

Published:2023-09 Issue: Volume:86 Page:104617
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Pindiprolu Sai Kiran S.S.^ORCID,Madhan Jitender^ORCID,Srinivasarao Dadi A.,Dasari Nagasen^ORCID,Phani Kumar Chirravuri. S.^ORCID,Katta Chantibabu,Sainaga Jyothi Vaskuri G.S.^ORCID

Funder

Science and Engineering Research Board

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference215 articles.

1. Triple-negative breast cancer;Foulkes;N. Engl. J. Med.,2010

2. Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer;Adams;Glycobiology,2018

3. Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells;Arase;Sci. Rep.,2017

4. Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells;Uemura;Glycoconj. J.,2014

5. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance;Dave;Breast Cancer Res.,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered bacteria-mediated augmentation of sialoglycan degradation strategy and immunogenic chemotherapy to boost effective cancer therapy;Chemical Engineering Journal;2024-09

2. Managing high disease burden: a study of medication rationality in diabetes and hypertension in Andhra Pradesh;Journal of Diabetes & Metabolic Disorders;2024-08-24

3. Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination;Frontiers in Oncology;2024-08-09

4. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31

5. Targeting triple negative breast cancer stem cells using nanocarriers;Discover Nano;2024-03-07